AMLX
Amylyx Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +5.9% ·
aliran saham +12.7% ·
posisi baru bersih +5.6%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +11 | 60.67M | $1.09B | +14 | −3 |
| Q1 2026 | 70 | -3 | 62.54M | $868.96M | +6 | −9 |
| Q4 2025 | 73 | 0 | 62.47M | $754.72M | — | — |
| Q3 2025 | 18 | +1 | 42.12M | $572.37M | +1 | — |
| Q2 2025 | 14 | -1 | 33.34M | $213.68M | — | −1 |
| Q1 2025 | 12 | +1 | 15.66M | $55.46M | +2 | −1 |
| Q4 2024 | 11 | 0 | 5.41M | $20.47M | +1 | −1 |
| Q3 2024 | 10 | +2 | 5.23M | $16.93M | +2 | — |
| Q2 2024 | 8 | — | 10.16M | $19.31M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 11.38M | +273.3% | $154.64M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasif) | 7.14M | +29.6% | $97.04M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 3 | Adage Capital Partners ✦ | 6.82M | -22.5% | $92.64M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 5.27M | +17.2% | $71.67M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Point72 Asset Management ✦ | 2.79M | -38.5% | $37.92M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 2.01M | — | $27.32M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 7 | Morgan Stanley ✦ | 1.95M | — | $26.50M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | Geode Capital Management ✦ (pasif) | 1.81M | +7.1% | $24.63M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | State Street Global Advisors ✦ (pasif) | 1.62M | +60.7% | $22.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 417.77K | -72.4% | $5.68M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Wellington Management ✦ | 236.20K | -18.2% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 12 | Citadel Advisors ✦ | 234.67K | -81.1% | $3.19M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | T. Rowe Price ✦ | 100.44K | +9.9% | $1.37M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 98.42K | -82.4% | $1.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 73.64K | Baru | $1.00M | 0.0% | New | 1 | SEC ↗ ×4 |
| 16 | JPMorgan Chase ✦ | 71.69K | — | $974,238 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 17 | D. E. Shaw & Co. ✦ | 68.88K | -54.5% | $936,038 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 19.90K | -95.0% | $270,441 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| AQR Capital Management | $1.00M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 170 pemegang, 113.99M saham, $1.58B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 30.00K lbr · $830,904
Officer, Director · 29.55K lbr · $950,040
Officer, Director · 919 lbr · $30,464
Officer · 9.53K lbr · $309,140
Officer · 11 lbr · $367
Officer · 9.77K lbr · $315,195
Officer · 1.04K lbr · $34,626
Officer · 7.95K lbr · $256,004
Officer · 2.08K lbr · $68,864
Officer, Director · 29.02K lbr · $932,553
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi